Birdshot chorioretinopathy (BCR) is a rare form of chronic, bilateral, posterior uveitis with a
distinctive clinical phenotype, and a strong association with HLA-A29. It predominantly …

Ocular immune privilege is a phenomenon described by Peter Medawar in relation to the
indefinite survival of the placement of foreign tissue grafts into the eye. Several mechanisms …

Drug delivery into the vitreous chamber remains a great challenge in the pharmaceutical
industry due to the complex anatomy and physiology of the eye. Intravitreal injection is the …

Macular edema (ME) is the leading cause of visual loss in uveitis and may persist long after
ocular inflammation has been resolved. Local steroids are the first line treatment for uveitis …

Uveitis refers to a broad group of inflammatory disorders of the eye that often require
medical and surgical management to improve or stabilize vision and prevent vision …

Introduction To evaluate real-life efficacy, safety, and treatment patterns with the
dexamethasone intravitreal implant (DEX) in posterior segment inflammation due to non …

Background Non-infectious intermediate uveitis, posterior uveitis and panuveitis are a
heterogeneous group of inflammatory eye disorders. Management includes local and …

Background This study aims to determine if the intravitreal dexamethasone implant (DEX
implant, Ozurdex; Allergan, Inc., Irvine, California) is effective for treating intermediate …

Ocular involvement in sarcoidosis occurs in∼ 40% and the eye is the presenting organ in
roughly 20%. The course of ocular disease does not necessarily parallel that of systemic …

Purpose: To investigate dexamethasone intravitreal implant (DEX implant; OZURDEX,
Allergan, Inc) in the treatment of uveitic cystoid macular edema that had persisted in the …